We are talking about synthetic blood, for example for treating the wounded without the need to refrigerate and transport ...

Joining me on today's call from Vir Biotechnology, Inc., are Dr. Marianne De Backer, our Chief Executive Officer, Dr. Mark D.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Biotechnology industry for Wednesday, February 25, 2026. Let’s ...

O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysisFDA Fast ...

FARGO — Fargo-Moorhead is home to a dozen billion-dollar businesses, a statistic that economic leaders say reflects not only ...

New research has found that at-home gut microbiome tests lack standardization, resulting in different results from the same ...

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full analysis FDA Fast Track designation offers clear pathway for ateganosine as ...

Pharma and life sciences accounted for 21% of UK healthcare M&A in 2025, down from 27% a year earlier, as inbound activity ...